{"name":"Cyterix Pharmaceuticals","permalink":"cyterix-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/cyterix-pharmaceuticals","homepage_url":"http://www.cyterix.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@cyterix.com","phone_number":"(415) 865-2059","description":"","created_at":"Wed Jun 08 03:16:35 UTC 2011","updated_at":"Wed Jun 08 03:16:34 UTC 2011","overview":"<p>Cyterix Pharmaceuticals, Inc., a privately held cancer therapeutics company, is engaged in the discovery and development of new classes of small molecule prodrugs with improved safety and efficacy over traditional drugs. The companyâ€™s approach, based on a proprietary technology platform, uniquely enables the design of multiple classes of anticancer prodrugs that are selectively activated by extra-hepatic cytochrome P450 enzymes that are greatly over-expressed in a broad range of solid tumor and hematologic cancers, but not in normal tissues.</p>","image":{"available_sizes":[[[150,41],"assets/images/resized/0013/8156/138156v1-max-150x150.png"],[[250,69],"assets/images/resized/0013/8156/138156v1-max-250x250.png"],[[280,78],"assets/images/resized/0013/8156/138156v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Founder and CEO","person":{"first_name":"Steven","last_name":"A. Everett","permalink":"steven-a-everett","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"Luis","last_name":"Bayol","permalink":"luis-bayol-2","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$9.2M","funding_rounds":[{"round_code":"a","source_url":"http://www.finsmes.com/2011/06/cyterix-pharmaceutics-raises-9-2m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cyterix Pharmaceutics Raises $9.2M in Series A Financing","raised_amount":9200000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":7,"investments":[{"company":null,"financial_org":{"name":"The Column Group","permalink":"the-column-group","image":{"available_sizes":[[[150,105],"assets/images/resized/0004/9539/49539v1-max-150x150.png"],[[230,162],"assets/images/resized/0004/9539/49539v1-max-250x250.png"],[[230,162],"assets/images/resized/0004/9539/49539v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"SV Life Sciences","permalink":"sv-life-sciences","image":{"available_sizes":[[[150,70],"assets/images/resized/0004/5361/45361v1-max-150x150.jpg"],[[250,117],"assets/images/resized/0004/5361/45361v1-max-250x250.jpg"],[[267,125],"assets/images/resized/0004/5361/45361v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"1700 Owens Street","address2":"Suite 500","zip_code":"94158","city":"San Francisco","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}